drugset / Trial / NCT04697602

Low-dose Colchicine With or Without Stepwise Dose Titration of Febuxostat for Flare Prophylaxis in Gout

NCT04697602

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the incidence rate of gout flare for subjects with gout and hyperuricemia treated by two different starting doses of febuxostat.

Timeline

Start
2021-01-20
Primary completion
2023-08-23
Completion
2023-08-23

Drugs

EvaluationDrugModalityDoseRoute
Comparator Febuxostat Small molecule 40 mg Oral
Comparator Colchicine Small molecule 0.5 mg Oral

Indications